News
Glenmark likely to make anti-viral Favipiravir to treat COVID-19
India’s Glenmark Pharmaceuticals, based in Mumbai, is getting ready to produce Japanese approved anti-viral, Favipiravir in the country to help treatment of COVID-19 patients.
Gilead issues statement on data from Remdesivir study in patients with severe COVID-19 in China
In the statement Gilead’s CMO Merdad Parsey says that the study was terminated early due to low enrollment and, as a result, it was underpowered to enable statistically meaningful conclusions.
BioNTech and Pfizer to initiate first COVID-19-related clinical trial in Germany
BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program.
Archives
India Biotech Handbook 2024
